Patent: 6,811,779
✉ Email this page to a colleague
Summary for Patent: 6,811,779
Title: | Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy |
Abstract: | The invention provides a method of reducing tumor growth in a mammal comprising treating the mammal with an effective amount of a combination of a VEGF receptor antagonist and radiation. In addition, the invention provides a method of reducing tumor growth in a mammal comprising treating the mammal with an effective amount of a combination of a VEGF receptor antagonist and a chemotherapeutic agent. |
Inventor(s): | Rockwell; Patricia (West Redding, CT), Goldstein; Neil I. (Maplewood, NJ) |
Assignee: | ImClone Systems Incorporated (New York, NY) |
Application Number: | 09/798,689 |
Patent Claims: | see list of patent claims |
Details for Patent 6,811,779
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2014-10-20 |
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2014-10-20 |
Servier Pharmaceuticals Llc | ONCASPAR | pegaspargase | Injection | 103411 | 02/01/1994 | ⤷ Try a Trial | 2014-10-20 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |